Colds as predictors of the onset and severity of copd exacerbations

International Journal of COPD

Volumn 12, Issue , 2017, Pages 839-848

  Johnston, Neil W ^a   Olsson, Marita ^b   Edsbäcker, Staffan ^c   de Verdier, Maria Gerhardsson ^d   Gustafson, Per ^e   McCrae, Christopher ^c   Coyle, Peter V ^f   McIvor, R Andrew ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Early Clinical Development Biometrics   (Sweden)

^c Inflammation Autoimmunity Unit   (Sweden)

^d Medical Evidence and Observational Research   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

^f ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Common cold; COPD epidemiology; COPD exacerbations; Respiratory infection; Respiratory viruses

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; THEOPHYLLINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMON COLD; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; PREDICTION; RESPIRATORY VIRUS; RISK ASSESSMENT; SELF REPORT; SYMPTOM; VERY ELDERLY; VIRUS DETECTION; DISEASE COURSE; ELECTRONIC HEALTH RECORD; LUNG; PATHOPHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VIROLOGY;

AGED; AGED, 80 AND OVER; COMMON COLD; DISEASE PROGRESSION; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 85015621012     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S127146     Document Type: Article

References (30)

1. Dhamane AD, Moretz C, Zhou Y, et al. COPD exacerbation frequency and its association with healthcare resource utilization and costs. Int J Chron Obstruct Pulmon Dis. 2015;10:2609–2618.
2. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12): 1128–1138.
3. Johnston SL. Overview of virus-induced airway disease. Proc Am Thorac Soc. 2005;2(2):150–156.
4. Upshur RE, Knight K, Goel V. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. Am J Epidemiol. 1999;149(1):85–92.
5. Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58(1):37–42.
6. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307(6910):982–986.
7. Seemungal TA, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164(9):1618–1623.
8. Hutchinson AF, Ghimire AK, Thompson MA, et al. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med. 2007;101(12):2472–2481.
9. Zwaans WAR, Mallia P, van Winden MEC, Rohde GG. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease – a systematic review. J Clin Virol. 2014;61: 181–188.
10. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000;115(5 suppl 2):380S–385S.
11. Seemungal TAR, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;161(5):1608–1613.
12. Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67(3):238–243.
13. Hurst JR, Donaldson TMA, Wilkinson WR, Perera WR, Wedzicha JA. Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J. 2005;26(5):846–852.
14. Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Medicine. 2013;11:181–191.
15. Johnston NW, McIvor RM, Lambert K, et al. The Christmas season as a risk factor for COPD exacerbations. Can Respir J. 2010;17(6): 275–281.
16. Johnston NW, Lambert K, Hussack P, et al. Detection of COPD exacerbations and compliance with patient reported daily symptom diaries using a smartphone-based information system. Chest. 2013;144(2): 507–514.
17. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204.
18. Mallia P, Message SD, Gielen V, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Resp Crit Care Med. 2011;183(6):734–742.
19. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol. 2005;116(2):267–273.
20. Gunawardana N, Finney L, Johnston SL, Mallia P. Experimental rhinovirus infection in COPD: implications for antiviral therapies. Antiviral Res. 2014;102:95–105.
21. Sajjan US. Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells. Curr Opin Pulm Med. 2013; 19(2):125–132.
22. Leidy NK, Wilcox TK, Jones PW, et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Am J Crit Care Med. 2011;183(3):323–329.
23. Mackay AJ, Donaldson GC, Anant RC, Singh R, Kowlessar B, Wedzicha JA. Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT). Eur Respir J. 2014;43:735–744.
24. Hewitt R, Farne H, Luke E, Johnston SL, Mallia P. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. 2016;10(2):158–174.
25. Kurai TS, Saraya T, Ishii H, Takizawa H. Virus induced exacerbations in asthma and COPD. Frontiers in microbiology. 2013;4:1–12.
26. Wark PAB, Tooze M, Powell H, et al. Viral and bacterial infection in acute asthma and chronic obstructive disease increases the risk of readmission. Respirology. 2013;18:996–1002.
27. Ma J, Ward EM, Siegel RI, Jemal A. Temporal trends in mortality in the United States, 1969–2013. JAMA. 2015;314(16):1731–1739.
28. Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature. COPD. 2006;3(4):211–218.
29. Shahab I, Jarvis MJ, Britton J, West R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12): 1043–1047.
30. Johnston NW, Olsson M, Edsbacker S, et al. Relationship of cold frequency and virus detection to exacerbations in COPD patients. Poster presented at: European Respiratory Society International Congress; September 26–30, 2015; Amsterdam, The Netherlands.